chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: HEP
Symptoms: Injection site erythema, Injection site rash, Pruritus, Rash, Rash erythematous
Clinical narrative: Patient called occupational health complaining of red rash on chest and injection site. Patient was also complaining of itchy scalp.  Patient was told to seek medical assistance by going to an urgent care or a doctor's office.  I called the patient to assess how she was doing later that day. She stated that she started to have wheezes when she first arrived at the ER. She stated that they treated her by giving her steroids, Benadryl and Albuterol to treat her reaction to the vaccine. She stated that she is doing a lot better now and her wheezing and red rash was improving.
Age: 34.0
Sex: F
Vaccine: HEP
Symptoms: Wheezing
Clinical narrative: Patient called occupational health complaining of red rash on chest and injection site. Patient was also complaining of itchy scalp.  Patient was told to seek medical assistance by going to an urgent care or a doctor's office.  I called the patient to assess how she was doing later that day. She stated that she started to have wheezes when she first arrived at the ER. She stated that they treated her by giving her steroids, Benadryl and Albuterol to treat her reaction to the vaccine. She stated that she is doing a lot better now and her wheezing and red rash was improving.
Age: 7.0
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given vaccine out of approved age range. Patient turned 7 and vaccine is approved until age 6. Patient had no adverse reaction, nurse was counseled on vaccine schedule.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient was given 0.25ml on 9/14/22, and came back on 9/16/22 for a full dose of 0.5ml
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was meant to receive the Pfizer bivalent booster, but instead received the pfizer monovalent vaccine. Pfizer drug safety report reference number: D3VH0R6L
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Adverse event, Condition aggravated, Depression, Fatigue, Feeling abnormal
Clinical narrative: Adverse event involved unexpected menstrual symptoms that triggered a severe premenstrual dysphoric disorder episode, which started on September 12th and lasted until the evening of September 15th. I experienced uncontrollable mood swings and irritability, followed by menstrual spotting, fatigue, and depression. My therapist was at hand during the peak of the episode, and paged in her supervisor and also notified my GP; I ended up missing two days of work and am still not at my best. PMDD is a known issue for me, but having it triggered so intensely by the booster was unexpected.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Impaired work ability, Intermenstrual bleeding, Irritability, Menstrual disorder, Mood swings
Clinical narrative: Adverse event involved unexpected menstrual symptoms that triggered a severe premenstrual dysphoric disorder episode, which started on September 12th and lasted until the evening of September 15th. I experienced uncontrollable mood swings and irritability, followed by menstrual spotting, fatigue, and depression. My therapist was at hand during the peak of the episode, and paged in her supervisor and also notified my GP; I ended up missing two days of work and am still not at my best. PMDD is a known issue for me, but having it triggered so intensely by the booster was unexpected.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Premenstrual dysphoric disorder
Clinical narrative: Adverse event involved unexpected menstrual symptoms that triggered a severe premenstrual dysphoric disorder episode, which started on September 12th and lasted until the evening of September 15th. I experienced uncontrollable mood swings and irritability, followed by menstrual spotting, fatigue, and depression. My therapist was at hand during the peak of the episode, and paged in her supervisor and also notified my GP; I ended up missing two days of work and am still not at my best. PMDD is a known issue for me, but having it triggered so intensely by the booster was unexpected.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Fear, Heart rate increased, Pain, Pyrexia, Respiratory rate increased
Clinical narrative: Fever of 103, accelerated heart rate and breathing, was scary,  pain throughout body started that night and went into the next day. Pain was not mild.  He still occasionally complain of rapid heart rate.  Went to urgent care and didn't it was taken seriously. Even heart rate when taken at the facility was not properly done.
Age: 38.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Red inflamed circle around injection site, warm to the touch; started about 36 hours after booster shot
Age: 69.0
Sex: M
Vaccine: FLUA4
Symptoms: Incorrect dose administered, Syringe issue, Wrong technique in product usage process
Clinical narrative: Partial dose given. Vaccine leaked at hub. Administered 2nd dose in opposite arm after calling office to get okay from nurse to administer 2nd dose. Partial dose given IM in right deltoid. Second complete dose given IM in left deltoid.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Hyponatraemia, Pyrexia
Clinical narrative: Patient came to the ED with fever and weakness.  Patient also had diarrhea.  Patient admitted to the hospital with Covid and hyponatremia and treated with remdesivir.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Pallor, Skin lesion
Clinical narrative: Left upper thigh with erythematous raised lesion that blanches; 3.5cm x 2.5cm
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Was here with 2 children and wife, infant and wife along with himself was getting vaccine. Was notified that he was given wrong vaccine pt was ok with it and was not up set. asked when he could get the vaccine that he came in for.
Age: 1.75
Sex: M
Vaccine: HEPA, UNK
Symptoms: Expired product administered
Clinical narrative: Vaccine was given to patient by mistake being expired.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient received 0.25ml on 9/14/22, and is returning on 9/19/22 to receive the full dose of 0.5ml.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotonia, Musculoskeletal stiffness, Pallor, Vision blurred
Clinical narrative: Patient was fine and breathing normally for the first couple of minutes after the vaccine.  About 2 minutes after his eye started to loose focus and his body went from limp to very stiff. Patients mother helped assist moving the patient to the floor until he got color back in his face about 5 minutes later. Patient remained laying down for about 30 minutes and slowly moved from sitting to standing over the next 10 minutes.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Body temperature increased, Seizure like phenomena
Clinical narrative: Patient reported to the ED with reports of seizure like activity 5-6 times with the onset at 7:00 pm. Patient temp upon arrival is 102.5 F. Patient was treated with 70mg Tylenol and temperature resolved. No further seizure like activity.  Patient was not postictal in the ED and had no witnessed seizure activity.  Advised to Follow up with PCP.  Patient was seen by PCP on 09/09/2022. Provider advised it is presumably an adverse effect from the DTaP vaccine. Patient appears well on exam, no further seizure-like activity.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site discolouration
Clinical narrative: After receiving his first Covid vaccine, mom noticed a very small bluish/black dot at the injection site. It was not swollen or painful. We were using a different brand needles than our usual so unsure if the spot was left from the needle or the vaccine itself.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Expired product administered
Clinical narrative: A pharmacy student administered an expired dose of Bexsero to a patient. It was the patient's second dose and the vaccine expired 8/2022. Patient was called and informed of situation - reported no SE/AE's and declined revaccination.
Age: 37.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Immediate post-injection reaction, Loss of consciousness, Presyncope
Clinical narrative: Few seconds after getting dose 2, client had vasovagal reaction. Patient was assisted, head protected and legs were elevated. Patient regained consciousness after 5 seconds. Ice pack was applied, water provided. Vitals signs taken X 4 and within normal limits. Patient left the site at 4:30 pm ambulatory and on stable condition.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Confusional state, Cough, Dyspnoea, Hypoxia
Clinical narrative: Patient came to ED with worsening shortness of breath, cough, and confusion.  Patient was admitted to the hospital with Covid and hypoxia and treated with remdesivir.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired when administered on 9/16/22.... Expiration date is 9/15/22.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was meant to receive the Pfizer bivalent booster but received the monovalent by mistake. Pfizer drug safety report reference number D3VH0R6L
Age: 0.33
Sex: M
Vaccine: HPV9
Symptoms: Wrong product administered
Clinical narrative: Patient was indicated to receive and father consented to provision of HiB vaccine. HPV was accidentally administered in its place by the Medical Assistant. Upon realization of the error, Dr (myself) called the family to report the error, explain what to expect, and to answer any questions or concerns. I called again the next day, about 18 hours after the error occurred. At that time, patient's mother reported no change in behavior or symptoms.
Age: 14.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient given Pfizer Bivalent as primary dose. No adverse signs and symptoms.
Age: 35.0
Sex: F
Vaccine: FLUC4
Symptoms: Exposure during pregnancy, Fatigue, Foetal hypokinesia, Somnolence, Vomiting
Clinical narrative: Day 0: fatigue, sleepiness, and emesis Day 1: fatigue and baby is moving less than usual  Treatment: Tylenol 250 mg on day 1 Time course: TBD
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient received a dose of 0.25ml on 9/14/22 but will be coming back next week to receive a full dose of 0.5ml.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: RECEIVED MONOVALENT INSTEAD OF BIVALENT AS THE 4TH SHOT
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Asthenia, Blood test, Chest pain, Dizziness
Clinical narrative: Tightness in neck/throat and hard to swallow, chest and severe heart pain, headaches, dizziness and lightheaded, stroke symptoms, extreme weak spells, fatigue, symptoms that keep persisting.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Electrocardiogram, Fatigue, Fibrin D dimer, Headache
Clinical narrative: Tightness in neck/throat and hard to swallow, chest and severe heart pain, headaches, dizziness and lightheaded, stroke symptoms, extreme weak spells, fatigue, symptoms that keep persisting.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Magnetic resonance imaging, Muscle tightness, Neurological symptom, Scan
Clinical narrative: Tightness in neck/throat and hard to swallow, chest and severe heart pain, headaches, dizziness and lightheaded, stroke symptoms, extreme weak spells, fatigue, symptoms that keep persisting.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, White blood cell count, X-ray
Clinical narrative: Tightness in neck/throat and hard to swallow, chest and severe heart pain, headaches, dizziness and lightheaded, stroke symptoms, extreme weak spells, fatigue, symptoms that keep persisting.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Asthenia, Decreased appetite, Dizziness
Clinical narrative: These symptoms apply to both me and my husband who got the injection at the same time.  Around 3:30  - 4 PM, I began to feel flushed, light-headed and VERY shaky, weak with some thirst and fatigue and a headache at the back of my head (I never get headaches).   NO FEVER.   At 4AM, 9/13/22, I began to  have severe body aches and stabling pains especially neck and shoulders at site of injection along with rapid heartbeat and mental fuzziness.  At 9:20 AM on 9/13/22, the same symptoms were there only stronger and a very strong all-over body sickness; so ill that both of us laid on the sofa with some nausea and increased leg pain and body aches, but there was also some pain at back of throat--no appetite and NO FEVER .  Late 9/13/22 the all-over sickness abated and felt fairly normal on Wednesday 9/14 and Thursday 9/15; however, today 9/16/22, the all-over body sickness, mild headache and body aches plus some stomach and GI upset have occurred.  The weakness is such that we not be active today.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Flushing, Headache, Heart rate increased
Clinical narrative: These symptoms apply to both me and my husband who got the injection at the same time.  Around 3:30  - 4 PM, I began to feel flushed, light-headed and VERY shaky, weak with some thirst and fatigue and a headache at the back of my head (I never get headaches).   NO FEVER.   At 4AM, 9/13/22, I began to  have severe body aches and stabling pains especially neck and shoulders at site of injection along with rapid heartbeat and mental fuzziness.  At 9:20 AM on 9/13/22, the same symptoms were there only stronger and a very strong all-over body sickness; so ill that both of us laid on the sofa with some nausea and increased leg pain and body aches, but there was also some pain at back of throat--no appetite and NO FEVER .  Late 9/13/22 the all-over sickness abated and felt fairly normal on Wednesday 9/14 and Thursday 9/15; however, today 9/16/22, the all-over body sickness, mild headache and body aches plus some stomach and GI upset have occurred.  The weakness is such that we not be active today.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Malaise, Mental impairment, Mobility decreased, Nausea
Clinical narrative: These symptoms apply to both me and my husband who got the injection at the same time.  Around 3:30  - 4 PM, I began to feel flushed, light-headed and VERY shaky, weak with some thirst and fatigue and a headache at the back of my head (I never get headaches).   NO FEVER.   At 4AM, 9/13/22, I began to  have severe body aches and stabling pains especially neck and shoulders at site of injection along with rapid heartbeat and mental fuzziness.  At 9:20 AM on 9/13/22, the same symptoms were there only stronger and a very strong all-over body sickness; so ill that both of us laid on the sofa with some nausea and increased leg pain and body aches, but there was also some pain at back of throat--no appetite and NO FEVER .  Late 9/13/22 the all-over sickness abated and felt fairly normal on Wednesday 9/14 and Thursday 9/15; however, today 9/16/22, the all-over body sickness, mild headache and body aches plus some stomach and GI upset have occurred.  The weakness is such that we not be active today.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Oropharyngeal pain, Pain, Pain in extremity, Thirst
Clinical narrative: These symptoms apply to both me and my husband who got the injection at the same time.  Around 3:30  - 4 PM, I began to feel flushed, light-headed and VERY shaky, weak with some thirst and fatigue and a headache at the back of my head (I never get headaches).   NO FEVER.   At 4AM, 9/13/22, I began to  have severe body aches and stabling pains especially neck and shoulders at site of injection along with rapid heartbeat and mental fuzziness.  At 9:20 AM on 9/13/22, the same symptoms were there only stronger and a very strong all-over body sickness; so ill that both of us laid on the sofa with some nausea and increased leg pain and body aches, but there was also some pain at back of throat--no appetite and NO FEVER .  Late 9/13/22 the all-over sickness abated and felt fairly normal on Wednesday 9/14 and Thursday 9/15; however, today 9/16/22, the all-over body sickness, mild headache and body aches plus some stomach and GI upset have occurred.  The weakness is such that we not be active today.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: These symptoms apply to both me and my husband who got the injection at the same time.  Around 3:30  - 4 PM, I began to feel flushed, light-headed and VERY shaky, weak with some thirst and fatigue and a headache at the back of my head (I never get headaches).   NO FEVER.   At 4AM, 9/13/22, I began to  have severe body aches and stabling pains especially neck and shoulders at site of injection along with rapid heartbeat and mental fuzziness.  At 9:20 AM on 9/13/22, the same symptoms were there only stronger and a very strong all-over body sickness; so ill that both of us laid on the sofa with some nausea and increased leg pain and body aches, but there was also some pain at back of throat--no appetite and NO FEVER .  Late 9/13/22 the all-over sickness abated and felt fairly normal on Wednesday 9/14 and Thursday 9/15; however, today 9/16/22, the all-over body sickness, mild headache and body aches plus some stomach and GI upset have occurred.  The weakness is such that we not be active today.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received the Pfizer monovalent vaccine when she was meant to receive the Pfizer bivalent vaccine. Pfizer drug safety report reference number: D3VH0R6L
Age: 33.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: PATIENT WAS INADVERTINLY GIVEN A MODERNA BIVALENT BOOSTER SHOT TOO EARLY. DUE TO THE VACCINE RECORD. HAVING POORLY WRITTEN VACCINATION DATES. PATIENT WAS NOTIFED ABOUT ERROR. PATIENT WAS UNAFFECTED BY ADDITIONAL DOSE. PATIENT HAD NO COMPLAINTS OR CONCERNS AS A RESULT OF THE ADDITIONAL DOSE.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Wrong product administered
Clinical narrative: Patient received the Pfizer monovalent vaccine, but was meant and expecting the Pfizer bivalent vaccine. Pfizer drug safety report reference number.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Fatigue, Headache, Injection site pain, Injection site pruritus
Clinical narrative: Four (4) days of severe body aches, disabiling fatigue, chills, feeling feverish, mild nausea, and headache. Extremely sore and swollen at the injection site with redness and itching. Soreness far exceeded past experience with Moderna vaccines. Symptoms lingered but did not lessen until the third day. Total of four days out of commission with three of those spent mostly in bed.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site swelling, Nausea, Pain, Pyrexia
Clinical narrative: Four (4) days of severe body aches, disabiling fatigue, chills, feeling feverish, mild nausea, and headache. Extremely sore and swollen at the injection site with redness and itching. Soreness far exceeded past experience with Moderna vaccines. Symptoms lingered but did not lessen until the third day. Total of four days out of commission with three of those spent mostly in bed.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF THE BIVALENT VACCINE
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Chills, Coordination abnormal, Cough, Decreased appetite
Clinical narrative: Head ache.  Vomiting.  Loss of urine control.  Weakness.  Loss of stability  -  falling down.  Fever - 101.3.  - Not wanting to eat.  Not much coordination. Fatigued.  Chills and sweats. Wheezing. Chest congestion.  Coughing.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fall, Fatigue, Gait disturbance, Headache, Hyperhidrosis
Clinical narrative: Head ache.  Vomiting.  Loss of urine control.  Weakness.  Loss of stability  -  falling down.  Fever - 101.3.  - Not wanting to eat.  Not much coordination. Fatigued.  Chills and sweats. Wheezing. Chest congestion.  Coughing.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory tract congestion, Urinary incontinence, Vomiting, Wheezing
Clinical narrative: Head ache.  Vomiting.  Loss of urine control.  Weakness.  Loss of stability  -  falling down.  Fever - 101.3.  - Not wanting to eat.  Not much coordination. Fatigued.  Chills and sweats. Wheezing. Chest congestion.  Coughing.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: I developed a deep cough on 09/04. I tested negative for COVID-19 on 09/05 and went to the urgent care that day. I was prescribed a cough medication. I tested positive on 09/06. I only have a cough but I'm still testing positive as of 9/15.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Patient was vaccinated a week earlier.  No adverse effect noted. Parent notified at 5pm, and concerns noted.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyspnoea, Fatigue
Clinical narrative: Extreme fatigue/tiredness, some SOB
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was meant to receive the Pfizer bivalent vaccine, but in turn received the Pfizer monovalent vaccine. Pfizer drug safety report reference number issued.
Age: 1.25
Sex: F
Vaccine: VARCEL
Symptoms: Injection site nodule
Clinical narrative: DEVELOPED NODULE AT INJECTION SITE, 1 WEEK AFTER INJECTION. NO TREATMENT AT THIS TIME JUST MONITORING.
Age: 90.0
Sex: F
Vaccine: FLU4
Symptoms: Chills, Dizziness, Flushing, Nausea
Clinical narrative: Patient reported feeling faint, flush, nausea,  and chills several hours after hours.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient death from COVID after full vaccination series of COVID vaccines ? Vaccines o 03/03/2021 Pfizer Lot EN5318 o 03/24/2021 Pfizer Lot EN6204 o 11/18/2021 Pfizer Lot FH8028
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: RECEIVED PFIZER MONOVALENT INSTEAD OF BIVALENT FOR THE 4TH DOSE
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: RECEIVED PFIZER MONOVALENT INSTEAD OF BIVALENT AS 4TH SHOT.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient received injection 24 hours after the vial was taken out of refrigerator.  Maximum, per guidelines, is 12 hours
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Death from COVID S/P COVID vaccination ? Vaccines o 01/21/2021 Pfizer Lot EL9291 o 02/11/2021 Pfizer Lot EL9269 o 02/19/2022 Pfizer Lot FM0698
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Contusion, Cough, Pain in extremity, Rhinorrhoea
Clinical narrative: After the vaccine I had pain in my arm and legs; I had 2 bruises in my leg I was concerned I called my doctor and he said to do ultrasound for a possible blood clot, but I was fine, no clots. A month later, I had a runny nose, coughing and I tested myself at home at I was Positive, and I went to a center and took the test again and it was Positive. The center gave me an antivirus, but I had reaction and stop taking it.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Ultrasound Doppler normal
Clinical narrative: After the vaccine I had pain in my arm and legs; I had 2 bruises in my leg I was concerned I called my doctor and he said to do ultrasound for a possible blood clot, but I was fine, no clots. A month later, I had a runny nose, coughing and I tested myself at home at I was Positive, and I went to a center and took the test again and it was Positive. The center gave me an antivirus, but I had reaction and stop taking it.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Bicuspid aortic valve, Cardiac murmur, Echocardiogram abnormal, Exercise tolerance decreased, Feeling abnormal
Clinical narrative: Patient's mother reports substantial disruption of the ability to conduct normal life functions about 4-6 months after receiving Pfizer vaccine including: heart palpitations, tachycardia, brain fog, fainting, migraine, nervous system damage, among others. He was a previous runner and can no longer enjoy running.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Migraine, Nervous system disorder, Palpitations, Tachycardia
Clinical narrative: Patient's mother reports substantial disruption of the ability to conduct normal life functions about 4-6 months after receiving Pfizer vaccine including: heart palpitations, tachycardia, brain fog, fainting, migraine, nervous system damage, among others. He was a previous runner and can no longer enjoy running.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: RECEIVED PFIZER MONOVALENT INSTEAD OF PFIZER BIOVALENT AS 4TH SHOT
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine was beyond use per the Pfizer website as of 8/31/22. The vaccine was marked on the box with a 10 week use by date (10 weeks post receiving the vaccine from dry ice). As such, patient was administered a vaccine that was expired 3 days prior.
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Vaccine administered 24 hours after being moved from refrigerator to room temperature
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Granuloma skin, Injection site granuloma, Injection site pain, Injection site swelling
Clinical narrative: 3 weeks post immunization the patient developed pain in his left arm where the vaccine was given.  He stated that there had been swelling in that area.  Upon examination there is a subcutaneous granuloma measuring 1.5x2.5cm.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, Bronchitis, COVID-19, COVID-19 pneumonia
Clinical narrative: DISCHARGE SUMMARY    Admit Date: 7/31/2022 Discharge Date: 08/02/22 Primary Care Physician: DO      Clinical Summary Patient is a 67 y.o. female with PMHx of ESRD s/p DDRT on immunosuppression, chronic HFpEF, HTN, T2DM, osteoporosis, and OSA. She presented to hospital on 7/31/2022 for shortness of breath, cough, fever, and fatigue. Found to have COVID. Chest imaging showed bronchitis and cardiomegaly with probable mild vascular congestion. Patient was treated with decadron while admitted due to brief O2 requirements. Improved with supportive care. Stable for discharge home.     Comments/Problems to be Addressed After Discharge ? Follow up with PCP for resolution of COVID symptoms. Repeat CBC once recovered from COVID to evaluate thrombocytopenia. ? Ensure follow up with renal and transplant physicians.      Discharge Diagnosis and Associated Hospital Course   Acute hypoxemic respiratory failure, resolved -Secondary to Covid-19 infection. No concern for superimposed bacterial infection or CHF exacerbation at this time. Inflammatory markers elevated. Chest imaging as above. Required brief O2 while admitted. Completed few days of decadron. Patient requested holding further decadron while admitted. Weaned to room air days prior to discharge.    COVID-19 infection in immunosuppressed patient COVID pneumonia, sepsis ruled out -With symptom onset 07/28/22. Tested positive on 07/31/22. Chest imaging as above. Briefly required O2 and decadron. Dry lung strategy maintained during admission. Continue OTC supportive care. Weaned to room air shortly following admission. Discussed with patient, will hold further decadron on discharge. Advised to wear mask around others through 8/6/22.  ESRD s/p DDRT -Per history. On mycophenolate and tacrolimus. Follows with Dr. Baseline Cr ~1.35, stable on admission. Continued immunosuppression. Recommend continued outpatient follow up.    Thrombocytopenia -Suspect due to COVID. PLT 105 on admission. No concerns of bleeding during admission. Recommend repeat CBC once COVID resolves.    Chronic HFpEF -Per history. Heart Association class III. Follows with Heart Clinic. Not on diuretics. Trace LE edema on exam. Echo on 11/2019 with EF 60-65%, grade II diastolic dysfunction. Pro-BNP 2078 on admission. Dry lung strategy maintained while admitted. Monitored for volume overload.    Essential HTN -Per history. On home nifedipine, carvedilol, clonidine,continued during admission. Continue losartan during discharge.   Osteoporosis -Per history. Diagnosed after recent DEXA scan. Takes calcium and vitamin D supplements at home. Continued.   Left Bell's palsy -Per history. With subsequent facial never paralysis.    T2DM -Per history. A1c 4.8 on admission. Diet controlled. Continue current lifestyle modifications   OSA  -Per history. Previously on CPAP. Not currently using. CPAP offered inpatient.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiomegaly, Cough, Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal
Clinical narrative: DISCHARGE SUMMARY    Admit Date: 7/31/2022 Discharge Date: 08/02/22 Primary Care Physician: DO      Clinical Summary Patient is a 67 y.o. female with PMHx of ESRD s/p DDRT on immunosuppression, chronic HFpEF, HTN, T2DM, osteoporosis, and OSA. She presented to hospital on 7/31/2022 for shortness of breath, cough, fever, and fatigue. Found to have COVID. Chest imaging showed bronchitis and cardiomegaly with probable mild vascular congestion. Patient was treated with decadron while admitted due to brief O2 requirements. Improved with supportive care. Stable for discharge home.     Comments/Problems to be Addressed After Discharge ? Follow up with PCP for resolution of COVID symptoms. Repeat CBC once recovered from COVID to evaluate thrombocytopenia. ? Ensure follow up with renal and transplant physicians.      Discharge Diagnosis and Associated Hospital Course   Acute hypoxemic respiratory failure, resolved -Secondary to Covid-19 infection. No concern for superimposed bacterial infection or CHF exacerbation at this time. Inflammatory markers elevated. Chest imaging as above. Required brief O2 while admitted. Completed few days of decadron. Patient requested holding further decadron while admitted. Weaned to room air days prior to discharge.    COVID-19 infection in immunosuppressed patient COVID pneumonia, sepsis ruled out -With symptom onset 07/28/22. Tested positive on 07/31/22. Chest imaging as above. Briefly required O2 and decadron. Dry lung strategy maintained during admission. Continue OTC supportive care. Weaned to room air shortly following admission. Discussed with patient, will hold further decadron on discharge. Advised to wear mask around others through 8/6/22.  ESRD s/p DDRT -Per history. On mycophenolate and tacrolimus. Follows with Dr. Baseline Cr ~1.35, stable on admission. Continued immunosuppression. Recommend continued outpatient follow up.    Thrombocytopenia -Suspect due to COVID. PLT 105 on admission. No concerns of bleeding during admission. Recommend repeat CBC once COVID resolves.    Chronic HFpEF -Per history. Heart Association class III. Follows with Heart Clinic. Not on diuretics. Trace LE edema on exam. Echo on 11/2019 with EF 60-65%, grade II diastolic dysfunction. Pro-BNP 2078 on admission. Dry lung strategy maintained while admitted. Monitored for volume overload.    Essential HTN -Per history. On home nifedipine, carvedilol, clonidine,continued during admission. Continue losartan during discharge.   Osteoporosis -Per history. Diagnosed after recent DEXA scan. Takes calcium and vitamin D supplements at home. Continued.   Left Bell's palsy -Per history. With subsequent facial never paralysis.    T2DM -Per history. A1c 4.8 on admission. Diet controlled. Continue current lifestyle modifications   OSA  -Per history. Previously on CPAP. Not currently using. CPAP offered inpatient.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Ejection fraction normal, Fatigue, Glycosylated haemoglobin normal, Imaging procedure abnormal, Inflammatory marker increased
Clinical narrative: DISCHARGE SUMMARY    Admit Date: 7/31/2022 Discharge Date: 08/02/22 Primary Care Physician: DO      Clinical Summary Patient is a 67 y.o. female with PMHx of ESRD s/p DDRT on immunosuppression, chronic HFpEF, HTN, T2DM, osteoporosis, and OSA. She presented to hospital on 7/31/2022 for shortness of breath, cough, fever, and fatigue. Found to have COVID. Chest imaging showed bronchitis and cardiomegaly with probable mild vascular congestion. Patient was treated with decadron while admitted due to brief O2 requirements. Improved with supportive care. Stable for discharge home.     Comments/Problems to be Addressed After Discharge ? Follow up with PCP for resolution of COVID symptoms. Repeat CBC once recovered from COVID to evaluate thrombocytopenia. ? Ensure follow up with renal and transplant physicians.      Discharge Diagnosis and Associated Hospital Course   Acute hypoxemic respiratory failure, resolved -Secondary to Covid-19 infection. No concern for superimposed bacterial infection or CHF exacerbation at this time. Inflammatory markers elevated. Chest imaging as above. Required brief O2 while admitted. Completed few days of decadron. Patient requested holding further decadron while admitted. Weaned to room air days prior to discharge.    COVID-19 infection in immunosuppressed patient COVID pneumonia, sepsis ruled out -With symptom onset 07/28/22. Tested positive on 07/31/22. Chest imaging as above. Briefly required O2 and decadron. Dry lung strategy maintained during admission. Continue OTC supportive care. Weaned to room air shortly following admission. Discussed with patient, will hold further decadron on discharge. Advised to wear mask around others through 8/6/22.  ESRD s/p DDRT -Per history. On mycophenolate and tacrolimus. Follows with Dr. Baseline Cr ~1.35, stable on admission. Continued immunosuppression. Recommend continued outpatient follow up.    Thrombocytopenia -Suspect due to COVID. PLT 105 on admission. No concerns of bleeding during admission. Recommend repeat CBC once COVID resolves.    Chronic HFpEF -Per history. Heart Association class III. Follows with Heart Clinic. Not on diuretics. Trace LE edema on exam. Echo on 11/2019 with EF 60-65%, grade II diastolic dysfunction. Pro-BNP 2078 on admission. Dry lung strategy maintained while admitted. Monitored for volume overload.    Essential HTN -Per history. On home nifedipine, carvedilol, clonidine,continued during admission. Continue losartan during discharge.   Osteoporosis -Per history. Diagnosed after recent DEXA scan. Takes calcium and vitamin D supplements at home. Continued.   Left Bell's palsy -Per history. With subsequent facial never paralysis.    T2DM -Per history. A1c 4.8 on admission. Diet controlled. Continue current lifestyle modifications   OSA  -Per history. Previously on CPAP. Not currently using. CPAP offered inpatient.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Oedema peripheral, Platelet count decreased, Prohormone brain natriuretic peptide increased, Pyrexia
Clinical narrative: DISCHARGE SUMMARY    Admit Date: 7/31/2022 Discharge Date: 08/02/22 Primary Care Physician: DO      Clinical Summary Patient is a 67 y.o. female with PMHx of ESRD s/p DDRT on immunosuppression, chronic HFpEF, HTN, T2DM, osteoporosis, and OSA. She presented to hospital on 7/31/2022 for shortness of breath, cough, fever, and fatigue. Found to have COVID. Chest imaging showed bronchitis and cardiomegaly with probable mild vascular congestion. Patient was treated with decadron while admitted due to brief O2 requirements. Improved with supportive care. Stable for discharge home.     Comments/Problems to be Addressed After Discharge ? Follow up with PCP for resolution of COVID symptoms. Repeat CBC once recovered from COVID to evaluate thrombocytopenia. ? Ensure follow up with renal and transplant physicians.      Discharge Diagnosis and Associated Hospital Course   Acute hypoxemic respiratory failure, resolved -Secondary to Covid-19 infection. No concern for superimposed bacterial infection or CHF exacerbation at this time. Inflammatory markers elevated. Chest imaging as above. Required brief O2 while admitted. Completed few days of decadron. Patient requested holding further decadron while admitted. Weaned to room air days prior to discharge.    COVID-19 infection in immunosuppressed patient COVID pneumonia, sepsis ruled out -With symptom onset 07/28/22. Tested positive on 07/31/22. Chest imaging as above. Briefly required O2 and decadron. Dry lung strategy maintained during admission. Continue OTC supportive care. Weaned to room air shortly following admission. Discussed with patient, will hold further decadron on discharge. Advised to wear mask around others through 8/6/22.  ESRD s/p DDRT -Per history. On mycophenolate and tacrolimus. Follows with Dr. Baseline Cr ~1.35, stable on admission. Continued immunosuppression. Recommend continued outpatient follow up.    Thrombocytopenia -Suspect due to COVID. PLT 105 on admission. No concerns of bleeding during admission. Recommend repeat CBC once COVID resolves.    Chronic HFpEF -Per history. Heart Association class III. Follows with Heart Clinic. Not on diuretics. Trace LE edema on exam. Echo on 11/2019 with EF 60-65%, grade II diastolic dysfunction. Pro-BNP 2078 on admission. Dry lung strategy maintained while admitted. Monitored for volume overload.    Essential HTN -Per history. On home nifedipine, carvedilol, clonidine,continued during admission. Continue losartan during discharge.   Osteoporosis -Per history. Diagnosed after recent DEXA scan. Takes calcium and vitamin D supplements at home. Continued.   Left Bell's palsy -Per history. With subsequent facial never paralysis.    T2DM -Per history. A1c 4.8 on admission. Diet controlled. Continue current lifestyle modifications   OSA  -Per history. Previously on CPAP. Not currently using. CPAP offered inpatient.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Thrombocytopenia
Clinical narrative: DISCHARGE SUMMARY    Admit Date: 7/31/2022 Discharge Date: 08/02/22 Primary Care Physician: DO      Clinical Summary Patient is a 67 y.o. female with PMHx of ESRD s/p DDRT on immunosuppression, chronic HFpEF, HTN, T2DM, osteoporosis, and OSA. She presented to hospital on 7/31/2022 for shortness of breath, cough, fever, and fatigue. Found to have COVID. Chest imaging showed bronchitis and cardiomegaly with probable mild vascular congestion. Patient was treated with decadron while admitted due to brief O2 requirements. Improved with supportive care. Stable for discharge home.     Comments/Problems to be Addressed After Discharge ? Follow up with PCP for resolution of COVID symptoms. Repeat CBC once recovered from COVID to evaluate thrombocytopenia. ? Ensure follow up with renal and transplant physicians.      Discharge Diagnosis and Associated Hospital Course   Acute hypoxemic respiratory failure, resolved -Secondary to Covid-19 infection. No concern for superimposed bacterial infection or CHF exacerbation at this time. Inflammatory markers elevated. Chest imaging as above. Required brief O2 while admitted. Completed few days of decadron. Patient requested holding further decadron while admitted. Weaned to room air days prior to discharge.    COVID-19 infection in immunosuppressed patient COVID pneumonia, sepsis ruled out -With symptom onset 07/28/22. Tested positive on 07/31/22. Chest imaging as above. Briefly required O2 and decadron. Dry lung strategy maintained during admission. Continue OTC supportive care. Weaned to room air shortly following admission. Discussed with patient, will hold further decadron on discharge. Advised to wear mask around others through 8/6/22.  ESRD s/p DDRT -Per history. On mycophenolate and tacrolimus. Follows with Dr. Baseline Cr ~1.35, stable on admission. Continued immunosuppression. Recommend continued outpatient follow up.    Thrombocytopenia -Suspect due to COVID. PLT 105 on admission. No concerns of bleeding during admission. Recommend repeat CBC once COVID resolves.    Chronic HFpEF -Per history. Heart Association class III. Follows with Heart Clinic. Not on diuretics. Trace LE edema on exam. Echo on 11/2019 with EF 60-65%, grade II diastolic dysfunction. Pro-BNP 2078 on admission. Dry lung strategy maintained while admitted. Monitored for volume overload.    Essential HTN -Per history. On home nifedipine, carvedilol, clonidine,continued during admission. Continue losartan during discharge.   Osteoporosis -Per history. Diagnosed after recent DEXA scan. Takes calcium and vitamin D supplements at home. Continued.   Left Bell's palsy -Per history. With subsequent facial never paralysis.    T2DM -Per history. A1c 4.8 on admission. Diet controlled. Continue current lifestyle modifications   OSA  -Per history. Previously on CPAP. Not currently using. CPAP offered inpatient.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Joint range of motion decreased, Pain, Peripheral swelling, Ultrasound scan
Clinical narrative: My arm felt sore around the deltoid muscle, which swelled.  This started to resolve, but returned on Monday, along with more swelling.  I saw PA on the 13th.  I could no longer fully extend or flex that arm.  It wasn't warm, or red - just swollen.  PA ordered an ultrasound which was done that afternoon.  The results were normal (no clots).  At this writing, the arm is still swollen, still painful on attempting full flexion or extension.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Erythema, Palpitations
Clinical narrative: Approximately 5 minutes after receiving Pfizer bivalent and Fluzone quad, patient felt dizzy and palpitation. upon observation patient's face appeared red. 911 was called. However within a minute patient started feeling better and didn't accept the Epipen. EMT team arrive and checked pt. Patient vital was normal and refuse to go to the hospital. patient was monitored for another 30 minutes. Patient had no additional symptom and confirmed she is feelin fine.
Age: 44.0
Sex: F
Vaccine: FLUC4
Symptoms: Chest discomfort, Dizziness, Nausea, Paraesthesia, Pharyngeal swelling
Clinical narrative: severe dizziness,  nausea, chest tightness,  throat feels swollen and face feels tingly
Age: 14.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: While administering vaccine dose to patient with parent in room, patient tensed up arm and moved away from Pharmacist which resulted in no vaccine being given to patient and a lost dose. New dose was readministered to patient because Pharmacist did not begin to administer vaccine before syringe was withdrawn from patient's arm.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine was beyond use per the Pfizer Inquiry website as of 8/31/22. The vaccine was marked on the box with a 10 week use by date (10 weeks post receiving the vaccine from dry ice). As such, patient was administered a vaccine that was expired 2 days prior.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was supposed to given primary dose of COVID PFizer MonoValent .03mL but accidentally received PFizer Bivalent .03mL as her first dose. After patient received vaccine, patient stayed the required 15 minutes in case of any  reaction. The patient did not get no reaction to vaccine and was free to go after.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardio-respiratory arrest, Death, Fall, General physical health deterioration
Clinical narrative: This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 01/04/2021, 01/25/2021, 11/30/2021, and 05/05/2022. They tested positive for COVID-19 on 07/25/2022 at the nursing home at which they were a resident. I see no indication they were hospitalized for this illness. They  experienced a cardiopulmonary arrest and died on 07/29/2022.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Illness, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 01/04/2021, 01/25/2021, 11/30/2021, and 05/05/2022. They tested positive for COVID-19 on 07/25/2022 at the nursing home at which they were a resident. I see no indication they were hospitalized for this illness. They  experienced a cardiopulmonary arrest and died on 07/29/2022.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood creatinine normal, Blood lactic acid, Blood potassium decreased, COVID-19
Clinical narrative: Clinical Summary: Patient is a 71 y.o. female with history of chronic fatigue and pain, atrial fibrillation (on Eliquis), and migraines, admitted to the hospital on 8/15/2022 for worsening weakness and fatigue. Her husband was diagnosed with COVID-19 ~10 days prior to this admission. She presented to ED previously on 8/13/22 and tested positive for COVID-19 herself. States for the week leading up to admission she has been feeling increased fatigue and generalized weakness. This has significantly worsened in 48 hours prior to admission to the point where she had decreased oral intake of both food and fluids. Husband felt overwhelmed and incapable of meeting her level of need at home. In the ED CBC and Chem7 were unremarkable. Lactic acid 1.4 and Creatinine 0.94. Chest and head imaging were non-acute. She was started on 75 mL / hr. of LR and PT/OT was consulted. She did not require supplemental oxygen at the time of admission or throughout her stay. Patient has a baseline level of low mood, anhedonia, and decreased functionality at home. She answers many questions with "I don't know" but is Aox4 and can go on to answer many questions after gentle probing. Her potassium did drop to 3.0 and was replete on 8/16. PT/OT saw the patient and recommended 2 - 3 days of rehab weekly for 7 - 10 days. The patient was approved for home health care through local service provider. She was discharged in stable condition. Discharge Diagnosis and Associated Hospital Course: Weakness Fatigue COVID-19 Infection Acute on chronic decompensation, presumably 2/2 COVID-19. Gave supportive care with IV fluids and encouraging PO intake. PT / OT saw patient and gave recommendations for outpatient rehabilitation. She was accepted and set up with local provider for her rehab. Atrial Fibrillation Cardiovascular Risk Longstanding diagnosis. Stable on Eliquis 5 mg BID and Simvastatin 20 mg daily at home. These medications were continued for this admission. Low Platelets. Patient was 127K on admission and decreased as low as 105K before rebounding. Presumed 2/2 dilution from IV fluids. Asymptomatic. Hypokalemia Patient was 3.8 on admission and dropped to 3.0. Replete with 80 mEq and on day of discharge was 3.7. Chronic Pain Peripheral Neuropathy Migraines Taking gabapentin 300 mg TID and Topamax 200 mg BID at home. Continued home medications. Insomnia Taking PRN Trazodone 150 mg nightly at home. Continued home medications. Peptic Ulcer Disease / GERD Taking Pepcid 40 mg and Protonix 40 mg daily at home. Continued home medications. Dry Eyes Taking Xiidra 5% droplets PRN at home. Gave liquid tears PRN in hospital.